USANA Health Sciences Reports Fourth Quarter and Full-Year 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
USANA Health Sciences (USNA) Tops Q4 EPS by 43c
February 4, 2020 4:23 PM ESTUSANA Health Sciences (NYSE: USNA) reported Q4 EPS of $1.41, $0.43 better than the analyst estimate of $0.98. Revenue for the quarter came in at $271.3 million versus the consensus estimate of $252.75 million.
Our fourth quarter results were stronger than expected and allowed us to finish the year strong, said Kevin Guest, Chief Executive... More
